NCT01360944View on ClinicalTrials.gov

Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Psoriasis
Interventions
DRUG

LAS41004

once daily, topical, 100 microgram

DRUG

reference

once daily, 100 microgram

Trial Locations (1)

Unknown

Investigational site, Mahlow

Sponsors

Lead Sponsor

Almirall, S.A.
All Listed Sponsors
collaborator

Sciderm GmbH

INDUSTRY

lead

Almirall, S.A.

INDUSTRY

NCT01360944 - Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test | Biotech Hunter | Biotech Hunter